跳至主要内容
临床试验/NCT00884468
NCT00884468已完成不适用

Anxiety and Depression in Patients With Psoriatic Arthritis: Prevalence and Characteristics

Wyeth is now a wholly owned subsidiary of Pfizer0 个研究点目标入组 384 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
384
主要终点
Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD)

研究概览

简要总结

This is an epidemiological non-interventional study assessing the prevalence of anxiety and/or depression disorders in patients suffering from Psoriatic Arthritis (PsA) in Spain.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Prevalence of anxiety and/or depression disorders in patients suffering from PsA in Spain as measured by the Hospital Anxiety and Depression Scale (HAD)

时间窗: 12 months

次要结局

  • To assess the relation between the PsA severity and the presence of anxiety and/or depression disorders in patients suffering from PsA in Spain.(12 months)

研究者

发起方
Wyeth is now a wholly owned subsidiary of Pfizer
申办方类型
Industry

相似试验